Ciclosidomine

This classification denotes a vasodilating agent and nitric oxide-releasing compound, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S7P608OW2O. European Medicines Agency schedules Ciclosidomine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06249MIG. Ciclosidomine generally arises in the molecular formula C13H20N4O3. The term CICLOSIDOMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, no. 10 1979, list 19.) CICLOSIDOMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ciclosidomine under HS 29349990 and SITC 51579. As of Q4 2014, CICLOSIDOMINE remains the US FDA Preferred Term for this commodity. Ciclosidomine bears US NLM identifiers UMLS ID C0055714 and NCI Concept Code C77149. SMILES: O1CCN([N]2NOC(/N=C(\O)C3CCCCC3)C2)CC1.